MedPath

Study on the Effect and Mechanism of Liangxuehuayuan Decoction in Increasing Efficacy and Reducing Toxicity in Radiotherapy of Esophageal Cancer

Phase 1
Conditions
Esophagus Cancer
Registration Number
ITMCTR2000003250
Lead Sponsor
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. The patient has a definite pathological and cytological diagnosis;
2. Peripheral white blood cells >= 4.0 x 10^9 / L, hemoglobin >= 90g / L, platelets >= 80 x 10^9 / L before radiotherapy;
3. KPS score >= 60 points, expected survival time> 3 months;
4. Liquid diet;
5. No esophageal perforation or active bleeding;
6. No serious heart, lung, liver and kidney function, coagulation dysfunction;
7. Cases in the experimental group still need to meet the Chinese medicine yin deficiency poison the diagnostic criteria for the syndrome of heat syndrome (prepared by Zhou Zhongying's Chinese Medicine): chest pain, poor sleep, low fever night sweats, or strong heat, thirst, dry stools, red tongue, yellow tongue coating, pulse count or large.

Exclusion Criteria

1. Patients with mental illness or intellectual disability;
2. Poor compliance;
3. Allergic to experimental drugs;
4. At the same time participating in other clinical trials;
5. Combining other serious diseases, such as other tumors or serious infections.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OS, PFS, RFS and TTP;Cytokines;CR, PR, SD, PD;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath